What's breaking now, across thousands of outlets.
NAFDAC said blood and blood products are classified as essential medicines and should be consistently available, with their quality, safety and affordability assured. The post NAFDAC strengthens regulatory oversight of blood products in Nigeria appeared first on Premium Times Nigeria .
We haven't written up this one. Premium Times has the full story — the link below goes straight to it.
New research suggests that newer blood thinners may not only protect against strokes but also support brain health in people with Alzheimer’s.
A federal appeals court ruled Thursday that international versions of Gilead's HIV drug Biktarvy differ materially from FDA-regulated U.S. versions
The new study is drawing fresh attention to a treatment whose use has steadily declined in the U.S. over the past two decades.
Hundreds of students from countries affected by Canada’s temporary Ebola travel restrictions could face changes to their academic plans as universities prepare for different scenarios.
Cytokinetics and Bristol Myers Squibb are fierce market rivals. Now they’re also rivals in court. Cytokinetics filed a lawsuit against Bristol Myers on Wednesday, seeking to invalidate a recently…
(MedPage Today) -- Adding genomic testing to routine newborn screening identified children at increased risk of developing certain childhood cancers, researchers found.
